Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances in riboflavin transporter RFVT and its genetic disease.

Pharmacology & therapeutics - 1 May 2022

Jin Congyun, Yonezawa Atsushi

Abstract excerpt

Riboflavin (vitamin B2) is essential for cellular growth and function. It is enzymatically converted to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which participate in the metabolic oxidation-reduction reactions of carbohydrates, amino acids, and lipids. Human riboflavin transporters RFVT1, RFVT2, and RFVT3 have been identified and characterized since 2008. They are highly specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hearing Loss, Sensorineural
Share to Membrane Transport Proteins
Share to Mice

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Riboflavin

Source

Identifiers

PMID: 34662687
DOI: 10.1016/j.pharmthera.2021.108023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in riboflavin transporter RFVT and its genetic disease.PMID 34662687Read ↗

Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52.Semantic proximity Read ↗

Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.Semantic proximity Read ↗

Impaired riboflavin transport due to missense mutations in <i>SLC52A2</i> causes Brown‐Vialetto‐Van Laere syndromeSemantic proximity Read ↗

An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.Semantic proximity Read ↗

Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice.Semantic proximity Read ↗

Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.Semantic proximity Read ↗

Impact of natural mutations on the riboflavin transporter 2 and their relevance to human riboflavin transporter deficiency 2.Semantic proximity Read ↗

Mitochondrial impairment and rescue in riboflavin responsive neuropathySemantic proximity Read ↗

SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters.Semantic proximity Read ↗

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavinSemantic proximity Read ↗

Riboflavin in Neurological Diseases: A Narrative Review.Semantic proximity Read ↗

Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.